138 related articles for article (PubMed ID: 20029473)
1. Time-trend in epidemiological and pathological features of schistosoma-associated bladder cancer.
Zaghloul MS; Nouh A; Moneer M; El-Baradie M; Nazmy M; Younis A
J Egypt Natl Canc Inst; 2008 Jun; 20(2):168-74. PubMed ID: 20029473
[TBL] [Abstract][Full Text] [Related]
2. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
[TBL] [Abstract][Full Text] [Related]
3. Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade.
Salem HK; Mahfouz S
Urology; 2012 Feb; 79(2):379-83. PubMed ID: 22112287
[TBL] [Abstract][Full Text] [Related]
4. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer.
El-Rifai W; Kamel D; Larramendy ML; Shoman S; Gad Y; Baithun S; El-Awady M; Eissa S; Khaled H; Soloneski S; Sheaff M; Knuutila S
Am J Pathol; 2000 Mar; 156(3):871-8. PubMed ID: 10702404
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
Khaled HM; Aly MS; Mokhtar N
Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
[TBL] [Abstract][Full Text] [Related]
6. Bilharziasis and bladder cancer: a time trend analysis of 9843 patients.
Gouda I; Mokhtar N; Bilal D; El-Bolkainy T; El-Bolkainy NM
J Egypt Natl Canc Inst; 2007 Jun; 19(2):158-62. PubMed ID: 19034337
[TBL] [Abstract][Full Text] [Related]
7. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization.
Muscheck M; Abol-Enein H; Chew K; Moore D; Bhargava V; Ghoneim MA; Carroll PR; Waldman FM
Carcinogenesis; 2000 Sep; 21(9):1721-6. PubMed ID: 10964104
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.
Abdulamir AS; Hafidh RR; Kadhim HS; Abubakar F
J Exp Clin Cancer Res; 2009 Feb; 28(1):27. PubMed ID: 19243595
[TBL] [Abstract][Full Text] [Related]
9. Bladder cancer in Africa.
Heyns CF; van der Merwe A
Can J Urol; 2008 Feb; 15(1):3899-908. PubMed ID: 18304401
[TBL] [Abstract][Full Text] [Related]
10. Incidence analyses of bladder cancer in the Nile delta region of Egypt.
Fedewa SA; Soliman AS; Ismail K; Hablas A; Seifeldin IA; Ramadan M; Omar HG; Nriagu J; Wilson ML
Cancer Epidemiol; 2009 Oct; 33(3-4):176-81. PubMed ID: 19762298
[TBL] [Abstract][Full Text] [Related]
11. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
[TBL] [Abstract][Full Text] [Related]
12. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
13. The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of endemic Schistosoma haematobium infection.
Kitinya JN; Laurèn PA; Eshleman LJ; Paljärvi L; Tanaka K
Trans R Soc Trop Med Hyg; 1986; 80(6):935-9. PubMed ID: 3111028
[TBL] [Abstract][Full Text] [Related]
14. The changing patterns of bladder cancer in Egypt over the past 26 years.
Felix AS; Soliman AS; Khaled H; Zaghloul MS; Banerjee M; El-Baradie M; El-Kalawy M; Abd-Elsayed AA; Ismail K; Hablas A; Seifeldin IA; Ramadan M; Wilson ML
Cancer Causes Control; 2008 May; 19(4):421-9. PubMed ID: 18188671
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammation and bladder cancer.
Michaud DS
Urol Oncol; 2007; 25(3):260-8. PubMed ID: 17483025
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 protein in bilharzial and non-bilharzial bladder cancers.
Gadalla HA; Kamel NA; Badary FA; Elanany FG
BJU Int; 2004 Jan; 93(1):151-5. PubMed ID: 14678388
[TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
[TBL] [Abstract][Full Text] [Related]
18. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathologic study of gynecologic organ involvement at radical cystectomy for bladder cancer.
Salem H; El-Mazny A
Int J Gynaecol Obstet; 2011 Nov; 115(2):188-90. PubMed ID: 21872241
[TBL] [Abstract][Full Text] [Related]
20. The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer.
Abdel-Rahman SZ; Anwar WA; Abdel-Aal WE; Ghoneim MA; Au WW
Cancer Lett; 1997 Oct; 119(1):115-22. PubMed ID: 18372530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
